FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Delta Group Investments Ltd

2. Date of Event Requiring Statement (MM/DD/YYYY)
12/31/2014 

3. Issuer Name and Ticker or Trading Symbol

Entia Biosciences, Inc. [ERGO]

(Last)        (First)        (Middle)

ROOM 2204, 22/F WEST TOWER,, SHUN TAK CENTRE, 200 CONNAUGHT RD. C.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

HONG KONG, K3 00000       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   991532   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Warrant   12/31/2014   12/31/2019   Common Stock   1790117   $0.01   D    
Common Stock Purchase Warrant   12/31/2014   12/31/2019   Common Stock   368750   $0.01   D    

Explanation of Responses:

Remarks:
Wah On Edward Wong is the managing director of Anka Consultants Limited, which is the sole director of Delta Group Investments Limited.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Delta Group Investments Ltd
ROOM 2204, 22/F WEST TOWER,
SHUN TAK CENTRE, 200 CONNAUGHT RD. C.
HONG KONG, K3 00000
X


Signatures
Delta Group Investments Limited by /s/ Edward Wong, Managing Dir. 9/30/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Entia Biosciences (CE) (USOTC:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Entia Biosciences (CE) Charts.
Entia Biosciences (CE) (USOTC:ERGO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Entia Biosciences (CE) Charts.